Molecular Diagnostics

In Other News

• Blood Test Receives FDA Breakthrough Status to Differentiate Schizophrenia and Bipolar Disorder

• Genomic Risk Score Identifies Inherited Risk for Multiple Cardiovascular Conditions

• Routine Genetic Marker May Help Guide Targeted Therapy in Acute Leukemia

• Proteomic Risk Score Predicts Kidney Disease Progression in High-Risk Patients

• Risk Prediction Tool Enhances Genetic Testing for Li-Fraumeni Syndrome

• Genetic Signature Predicts Myeloid Leukemia Risk in Down Syndrome

• New Molecular Insights Support Diagnosis of Hodgkin Lymphoma

• Gene Expression Model Guides Neoadjuvant Therapy Selection in Breast Cancer

• Collaboration Expands Access to Rapid Metagenomic Diagnostics for Complex Infections

• AI Blood Test Enhances Monitoring of Liver Cirrhosis Progression

• Cancer-Related Mutations in Immune Cells Linked to Alzheimer’s

• Composite Blood Biomarkers Enable Early Detection of Common Cancers

• Gut Microbiome Test Predicts Melanoma Recurrence After Surgery

• Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

• Blood Test Enables Early Detection and Classification of Glioma

• Multi-Biomarker Blood Test Detects Early-Stage Cancers Across Types

• New Sample-to-Answer PCR System Supports High-Throughput Infectious Disease Testing

• Seegene Showcases Real-Time PCR Data Analytics Platform at ESCMID

• Framework Guides Targeted Immunotherapy Selection in Liver Cancer

• Collaboration Brings Rapid At-Home STI Testing with Virtual Follow-Up

• Blood-Based Epigenetic Signals Enable Osteosarcoma Disease Monitoring

• Host–Virus Genetic Interactions Drive Nasopharyngeal Cancer Risk

• AI-Enabled Biochip Detects microRNA Biomarkers in Minutes